A US federal court’s ruling late Wednesday against President Donald Trump’s authority to levy some of his most sweeping ...

The White House would like some control of U.S. Steel if it approves its sale to Nippon Steel. Such deals could alter foreign ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque. But drug companies and other stakeholders would reap the benefits of such ...

Shein Group Ltd. is considering switching its planned initial public offering to Hong Kong from London, people familiar with ...

President Donald Trump’s proposal to peg US drug prices to those paid abroad includes granting the FDA legal authority to ...

Mint's Plain Facts section brings out an update on key global data to thread together the biggest developments in the world ...